Chagas disease in latin american immigrants with dilated cardiomyopathy in New York City

Clinical Infectious Diseases

Volumn 57, Issue 1, 2013, Pages

  Kapelusznik, Luciano ^a   Varela, Deborah ^b   Montgomery, Susan P ^e   Shah, Arti N ^d   Steurer, Francis J ^e   Rubinstein, David ^d   Caplivski, Daniel ^b   Pinney, Sean P ^c   Turker, Dana ^b   Factor, Stephanie H ^b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b Division of Infectious Diseases   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^d ELMHURST HOSPITAL CENTER   (United States)

^e CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

cardiomyopathy; Chagas disease; Trypanosoma cruzi; United States

Indexed keywords

ADULT; ARTICLE; CHAGAS DISEASE; CLINICAL ARTICLE; CONGESTIVE CARDIOMYOPATHY; FEMALE; HUMAN; IMMIGRANT; MALE; PREVALENCE; PRIORITY JOURNAL; SOUTH AND CENTRAL AMERICA;

CARDIOMYOPATHY; CHAGAS DISEASE; TRYPANOSOMA CRUZI; UNITED STATES;

ADULT; AGED; CARDIOMYOPATHY, DILATED; CHAGAS CARDIOMYOPATHY; EMIGRANTS AND IMMIGRANTS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEW YORK CITY; PREVALENCE;

EID: 84878856203     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cit199     Document Type: Article

References (14)

1. Rassi A, Rassi A, Little WC. Chagas' heart disease. Clin Cardiol 2000; 23:883-9.
2. US Census Bureau. 2010 American community survey. Available at: http://www.census.gov/prod/2011pubs/acsbr10-15.pdf. Accessed 6 July 2012.
3. Bern C, Montgomery SP, Herwaldt BL, et al. Evaluation and treatment of Chagas disease in the United States: a systematic review. JAMA 2007; 298:2171-81. (Pubitemid 350106656)
4. Rassi A, Rassi A, Marin-Neto JA. Chagas disease. Lancet 2010; 375: 1388-402.
5. Viotti R, Vigliano C, Lococo B, et al. Long-term cardiac outcomes of treating chronic Chagas disease with benznidazole versus no treatment: a nonrandomized trial. Ann Intern Med 2006; 144:724-34. (Pubitemid 46780632)
6. Umezawa ES, Nascimento MS, Stolf AM. Enzyme-linked immunosorbent assay with Trypanosoma cruzi excreted-secreted antigens (TESAELISA) for serodiagnosis of acute and chronic Chagas' disease. Diagn Microbiol Infect Dis 2001; 39:169-76. (Pubitemid 32406173)
7. Traina M, Hernandez S, Smer A, et al. Prevalence of Chagas disease in U.S. Latin American immigrant population with cardiomyopathy. In: 58th Annual Meeting of the American Society of Tropical Medicine and Hygiene, 18-22 November 2009;Washington, DC.
8. Pereira Nunes Mdo C, Barbosa MM, Ribeiro AL, Amorim Fenelon LM, Rocha MO. Predictors of mortality in patients with dilated cardiomyopathy: relevance of chagas disease as an etiological factor. Rev Esp Cardiol 2010; 63:788-97.
9. Barbosa AP, Cardinalli Neto A, Otaviano AP, Rocha BF, Bestetti RB. Comparison of outcome between Chagas cardiomyopathy and idiopathic dilated cardiomyopathy. Arq Bras Cardiol 2011; 97: 517-25.
10. Bestetti RB, Muccillo G. Clinical course of Chagas' heart disease: a comparison with dilated cardiomyopathy. Int J Cardiol 1997; 60: 187-93. (Pubitemid 27304383)
11. Bocchi EA, Fiorelli A. The paradox of survival results after heart transplantation for cardiomyopathy caused by Trypanosoma cruzi. First Guidelines Group for Heart Transplantation of the Brazilian Society of Cardiology. Ann Thorac Surg 2001; 71:1833-8. (Pubitemid 32554410)
12. Diez M, Favaloro L, Bertolotti A, et al. Usefulness of PCR strategies for early diagnosis of Chagas' disease reactivation and treatment follow-up in heart transplantation. Am J Transplant 2007; 7:1633-40. (Pubitemid 46776258)
13. Elizari MV, Chiale PA. Cardiac arrhythmias in Chagas' heart disease. J Cardiovasc Electrophysiol 1993; 4:596-608. (Pubitemid 23302173)
14. Marin-Neto JA, Rassi A Jr, Avezum A Jr, et al. The BENEFIT trial: testing the hypothesis that trypanocidal therapy is beneficial for patients with chronic Chagas heart disease. Mem Inst Oswaldo Cruz 2009; 1:319-24.